Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Increased levels of the inflammatory biomarker C-reactive protein at baseline are associated with childhood sickle cell vasocclusive crises.

Krishnan S, Setty Y, Betal SG, Vijender V, Rao K, Dampier C, Stuart M.

Br J Haematol. 2010 Mar;148(5):797-804. doi: 10.1111/j.1365-2141.2009.08013.x. Epub 2009 Dec 8.

2.

Angiogenic and inflammatory markers of cardiopulmonary changes in children and adolescents with sickle cell disease.

Niu X, Nouraie M, Campbell A, Rana S, Minniti CP, Sable C, Darbari D, Dham N, Reading NS, Prchal JT, Kato GJ, Gladwin MT, Castro OL, Gordeuk VR.

PLoS One. 2009 Nov 23;4(11):e7956. doi: 10.1371/journal.pone.0007956.

3.

Elevated circulating stromal-derived factor-1 levels in sickle cell disease.

Landburg PP, Nur E, Maria N, Brandjes DP, Biemond BJ, Schnog JB, Duits AJ; CURAMA Study Group.

Acta Haematol. 2009;122(1):64-9. doi: 10.1159/000243727. Epub 2009 Oct 7.

PMID:
19816012
4.

Measuring the poise of thiol/disulfide couples in vivo.

Jones DP, Liang Y.

Free Radic Biol Med. 2009 Nov 15;47(10):1329-38. doi: 10.1016/j.freeradbiomed.2009.08.021. Epub 2009 Aug 26.

5.

Bone marrow mobilization with granulocyte macrophage colony-stimulating factor improves endothelial dysfunction and exercise capacity in patients with peripheral arterial disease.

Subramaniyam V, Waller EK, Murrow JR, Manatunga A, Lonial S, Kasirajan K, Sutcliffe D, Harris W, Taylor WR, Alexander RW, Quyyumi AA.

Am Heart J. 2009 Jul;158(1):53-60.e1. doi: 10.1016/j.ahj.2009.04.014.

PMID:
19540392
6.

Elevated endothelial progenitor cells during painful sickle cell crisis.

van Beem RT, Nur E, Zwaginga JJ, Landburg PP, van Beers EJ, Duits AJ, Brandjes DP, Lommerse I, de Boer HC, van der Schoot CE, Schnog JJ, Biemond BJ; CURAMA Study Group.

Exp Hematol. 2009 Sep;37(9):1054-9. doi: 10.1016/j.exphem.2009.06.003. Epub 2009 Jun 17.

PMID:
19539689
7.

Erythrocyte hemolysis and hemoglobin oxidation promote ferric chloride-induced vascular injury.

Woollard KJ, Sturgeon S, Chin-Dusting JP, Salem HH, Jackson SP.

J Biol Chem. 2009 May 8;284(19):13110-8. doi: 10.1074/jbc.M809095200. Epub 2009 Mar 10.

8.

Prediction of adverse outcomes in children with sickle cell anemia: a study of the Dallas Newborn Cohort.

Quinn CT, Lee NJ, Shull EP, Ahmad N, Rogers ZR, Buchanan GR.

Blood. 2008 Jan 15;111(2):544-8. Epub 2007 Oct 1.

9.

Sickle cell disease: role of reactive oxygen and nitrogen metabolites.

Wood KC, Granger DN.

Clin Exp Pharmacol Physiol. 2007 Sep;34(9):926-32. Review.

PMID:
17645642
10.

Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors.

Case J, Mead LE, Bessler WK, Prater D, White HA, Saadatzadeh MR, Bhavsar JR, Yoder MC, Haneline LS, Ingram DA.

Exp Hematol. 2007 Jul;35(7):1109-18.

PMID:
17588480
11.

Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes.

Kato GJ, Gladwin MT, Steinberg MH.

Blood Rev. 2007 Jan;21(1):37-47. Epub 2006 Nov 7. Review.

12.

Serum levels of angiogenic factors indicate a pro-angiogenic state in adults with sickle cell disease.

Duits AJ, Rodriguez T, Schnog JJ; CURAMA Study Group.

Br J Haematol. 2006 Jul;134(1):116-9.

PMID:
16803577
13.

Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease.

Walter DH, Haendeler J, Reinhold J, Rochwalsky U, Seeger F, Honold J, Hoffmann J, Urbich C, Lehmann R, Arenzana-Seisdesdos F, Aicher A, Heeschen C, Fichtlscherer S, Zeiher AM, Dimmeler S.

Circ Res. 2005 Nov 25;97(11):1142-51. Epub 2005 Oct 27.

14.

Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists.

Bahlmann FH, de Groot K, Mueller O, Hertel B, Haller H, Fliser D.

Hypertension. 2005 Apr;45(4):526-9. Epub 2005 Mar 14.

15.

Endothelial progenitor cells during cerebrovascular disease.

Ghani U, Shuaib A, Salam A, Nasir A, Shuaib U, Jeerakathil T, Sher F, O'Rourke F, Nasser AM, Schwindt B, Todd K.

Stroke. 2005 Jan;36(1):151-3. Epub 2004 Dec 2.

16.

Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase.

Landmesser U, Engberding N, Bahlmann FH, Schaefer A, Wiencke A, Heineke A, Spiekermann S, Hilfiker-Kleiner D, Templin C, Kotlarz D, Mueller M, Fuchs M, Hornig B, Haller H, Drexler H.

Circulation. 2004 Oct 5;110(14):1933-9.

17.

Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction.

Massa M, Rosti V, Ferrario M, Campanelli R, Ramajoli I, Rosso R, De Ferrari GM, Ferlini M, Goffredo L, Bertoletti A, Klersy C, Pecci A, Moratti R, Tavazzi L.

Blood. 2005 Jan 1;105(1):199-206. Epub 2004 Sep 2.

18.

Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes.

Loomans CJ, de Koning EJ, Staal FJ, Rookmaaker MB, Verseyden C, de Boer HC, Verhaar MC, Braam B, Rabelink TJ, van Zonneveld AJ.

Diabetes. 2004 Jan;53(1):195-9.

19.

Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin.

Bahlmann FH, DeGroot K, Duckert T, Niemczyk E, Bahlmann E, Boehm SM, Haller H, Fliser D.

Kidney Int. 2003 Nov;64(5):1648-52.

20.

Circulating endothelial progenitor cells, vascular function, and cardiovascular risk.

Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T.

N Engl J Med. 2003 Feb 13;348(7):593-600.

Supplemental Content

Support Center